MONIQUE BRUMSEY: Open Payments
NPI 1831709062 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,870 in 85 payments from 19 companies in 2025. Trend: 2023 $1,343 · 2024 $1,557 · 2025 $1,870
Food & beverage: $1,775Education: $95
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 21 | $389 |
| Janssen Biotech, Inc. | 18 | $326 |
| Medtronic, Inc. | 1 | $196 |
| Endo USA, Inc. | 7 | $153 |
| Astellas Pharma US Inc | 9 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $124 |
| Antares Pharma, Inc. | 4 | $73 |
| Boston Scientific Corporation | 3 | $65 |
| Ferring Pharmaceuticals Inc. | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
Products named: ERLEADA, ORGOVYX, INTERSTIM, GEMTESA, XTANDI, Nubeqa, AVEED, XYOSTED.
Industry payments across TX — which companies pay providers there.
